Meribank Biotech Co (ROCO:4724) Total Stockholders Equity : NT$661.7 Mil (As of Dec. 2023)

View and export this data going back to 2023. Start your Free Trial

What is Meribank Biotech Co Total Stockholders Equity?

Meribank Biotech Co's Total Stockholders Equity for the quarter that ended in Dec. 2023 was NT$661.7 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Meribank Biotech Co's Book Value per Share for the quarter that ended in Dec. 2023 was NT$9.32. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Meribank Biotech Co's Debt-to-Equity for the quarter that ended in Dec. 2023 was 0.05.

Meribank Biotech Co Total Stockholders Equity Historical Data

The historical data trend for Meribank Biotech Co's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Meribank Biotech Co Total Stockholders Equity Chart

Meribank Biotech Co Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Stockholders Equity

Get a 7-Day Free Trial

434.36

382.64

586.05

471.20

661.73

Meribank Biotech Co Semi-Annual Data
	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Total Stockholders Equity	Get a 7-Day Free Trial							586.05	529.73	471.20	406.20	661.73

Meribank Biotech Co (ROCO:4724) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Meribank Biotech Co's Book Value per Share for the quarter that ended in Dec. 2023 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(661.732	-	0)	/	70.9764
	=	9.32

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Meribank Biotech Co's Debt-to-Equity for the quarter that ended in Dec. 2023 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(19.228	+	14.811)	/	661.732
	=	0.05

Meribank Biotech Co Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Meribank Biotech Co's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Meribank Biotech Co (ROCO:4724) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Meribank Biotech Co Ltd (ROCO:4724) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

Sector 1, Neihu Road, 1st Floor, No.68, Neihu District, Taipei, TWN, 11493

Website

http://www.meribank.com.tw

Meribank Biotech Co Ltd is engaged in Research and development and sales of new cell drugs and also Umbilical cord blood, placenta and umbilical cord mesenchymal stem cells processing, testing and cryopreservation.

Meribank Biotech Co (ROCO:4724) Headlines

No Headlines